The Roller Coaster Ride: Optimizing the Therapeutic Alliance with Patients with Bipolar Disorder

Bipolar disorder may be categorized as a “chronic, cyclic disease” (2). As with other chronic illnesses, prolonged, close adherence to a treatment regimen is necessary for optimal prognosis. Despite an increase in the number of effective medications, the efficacy–effectiveness gap in clinical practice suggests that adherence is a major problem in the treatment of bipolar disorder and one that contributes substantially to the burden of morbidity and mortality of the illness (3). The term “compliance” has been used to describe whether or not a patient follows the treatment recommendations of the physician. However, this term connotes a passive acceptance bythepatienttotherecommendedtreatmentandassumesthat “the doctor knows best.” Although physicians do have knowledge about illness and effective treatments, the needs of each patient in terms of understanding and accepting their illness, lifestyle, culture, values, religion, and other factors are crucial in crafting the most effective treatment plan (4). Patients who feel listened to, who feel that their needs and desires are taken seriously, and who are involved in their treatment planning tend to be more adherent to treatment (5). Bultman and Svarstad (6) found that a “collaborative or participatory communication style”between physician and patient had a positive impact on treatment and medication adherence. This communication style encouraged mutual exchange of information between patient and doctor, highlighted listening to each other’s point of view, considered treatment a partnership for solving problems and resolving confl ict, and emphasized the patient’s active role in treatment planning. Adherence to medication in bipolar disorder may be influenced by a number of patient, physician, environment, illness, and treatment variables. Full adherence to medication treatmentinbipolardisorderisnotthe norm—adherence is typically partial or intermittent (7). For individuals in the hypomanic to manic phase of the disease, the euphoria may be compelling, decreasing the patient’s motivation to take medication to quell this “high.” For individuals in the depths of depression, lack of motivation, apathy, and passive or active self-destructive wishes may impair treatment adherence. Patients’ fear of side effects and negative attitudes toward long-term prophylaxis for bipolar disorder may influence adherence to medication more than experiencing actual adverse reactions to medications (8). These factors make a strong treatment alliance particularly crucial in the treatment of patients with bipolar illness. Psychosocial interventions such as psychoeducation, participatory treatment planning, and a supportive collaborative care network improve prognosis.